These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 8594229)

  • 1. Changes ahead in childhood immunization.
    Marwick C
    JAMA; 1996 Feb; 275(8):582. PubMed ID: 8594229
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis A and vaccination.
    Teuwen DE
    Arch Inst Pasteur Tunis; 1994; 71(3-4):549-56. PubMed ID: 8801857
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatitis A vaccine.
    Med Lett Drugs Ther; 1995 Jun; 37(950):51-2. PubMed ID: 7760768
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunogenicity and safety of an inactivated hepatitis A vaccine administered concomitantly with diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines to children less than 2 years of age.
    Nolan T; Bernstein H; Blatter MM; Bromberg K; Guerra F; Kennedy W; Pichichero M; Senders SD; Trofa A; Collard A; Sullivan DC; Descamps D
    Pediatrics; 2006 Sep; 118(3):e602-9. PubMed ID: 16950952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical immunogenicity and tolerance studies of liquid vaccines delivered by jet-injector and a new single-use cartridge (Imule): comparison with standard syringe injection. Imule Investigators Group.
    Parent du Châtelet I; Lang J; Schlumberger M; Vidor E; Soula G; Genet A; Standaert SM; Saliou P
    Vaccine; 1997 Mar; 15(4):449-58. PubMed ID: 9141217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hepatitis A vaccine].
    Mussa GC; Borgione S; Mussa F; Silvestro L
    Minerva Pediatr; 1995 Nov; 47(11):439-44. PubMed ID: 8684338
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunogenicity of an inactivated hepatitis A pediatric vaccine: three-year post-booster follow-up.
    Dagan R; Greenberg D; Weber F
    Vaccine; 2005 Oct; 23(44):5144-8. PubMed ID: 16043271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1996 Dec; 45(RR-15):1-30. PubMed ID: 9005304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent administration of rhesus rotavirus tetravalent (RRV-TV) vaccine with pentavalent diphtheria-pertussis-tetanus-Haemophilus influenzae beta-inactivated polio and hepatitis B vaccines.
    Vesikari T; Joensuu J; Baer M; Käyhty H; Olander RM; Sormunen H; Miettinen A; Ward RL; Guillot T
    Acta Paediatr; 1999 May; 88(5):513-20. PubMed ID: 10426173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis A vaccine: which dose is best?
    Lonergan G
    JAMA; 1995 Apr; 273(13):999-1000. PubMed ID: 7897815
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine (DTaP-IPV) compared to separate administration of standalone DTaP and IPV vaccines: a randomized, controlled study in infants in the Republic of Korea.
    Lee SY; Hwang HS; Kim JH; Kim HH; Lee HS; Chung EH; Park SE; Ma SH; Chang JK; Guitton F; Ortiz E; Kang JH
    Vaccine; 2011 Feb; 29(8):1551-7. PubMed ID: 21215828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.
    Grimprel E; von Sonnenburg F; Sänger R; Abitbol V; Wolter JM; Schuerman LM
    Vaccine; 2005 May; 23(28):3657-67. PubMed ID: 15882526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative study of the immunogenicity of the inactivated hepatitis A vaccine Hep-A-in-vac from experimental and clinical data].
    Karpovich LG; Kalashnikova TV; Gorbunov MA; Pavlova LI; Bektimirov TA; Maĭdaniuk AG; Sandakhchiev LS; Levina VD; Ermolaeva TN; Rodomazova TA
    Vopr Virusol; 1995; 40(6):268-70. PubMed ID: 8686264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thermostability of an inactivated hepatitis A vaccine stored at 37 degrees C for one week.
    Wiedermann G; Ambrosch F; André FE; Delem A; D'Hondt E; Safary A
    J Med Virol; 1994 Dec; 44(4):442. PubMed ID: 7897377
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatitis A vaccine for secondary hepatitis A infection.
    Monto AS; Victor JC
    Lancet; 1999 Jul; 354(9175):341-2; author reply 342-3. PubMed ID: 10440344
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatitis A: infection, detection, vaccination and immunity.
    van Hattum J; Chen XQ
    Neth J Med; 1999 Sep; 55(3):142-50. PubMed ID: 10509073
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatitis A vaccine for secondary hepatitis A infection.
    Bell BP; Margolis HS
    Lancet; 1999 Jul; 354(9175):341; author reply 342-3. PubMed ID: 10440343
    [No Abstract]   [Full Text] [Related]  

  • 18. Simultaneous administration of diphtheria/tetanus/pertussis/polio vaccine and hepatitis B vaccine in a simplified immunization programme.
    Coursaget P; Yvonnet B; Relyveld EH; Barres JL; Diop-Mar I; Chiron JP
    Dev Biol Stand; 1986; 65():169-75. PubMed ID: 2881821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humoral immunity of dTap-IPV vaccine (REPEVAX®) administered one month after dT-IPV vaccine (REVAXIS®) in adults with unknown vaccination history.
    Larnaudie S; Guiso N; Baptiste C; Desaint C; Desforges L; Lebon P; Soubeyrand B; Launay O
    Hum Vaccin; 2010 Oct; 6(10):829-34. PubMed ID: 20864810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis A vaccine for secondary hepatitis A infection.
    Shouval D; Ashur Y
    Lancet; 1999 Jul; 354(9175):342-3. PubMed ID: 10440345
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.